Musk’s company says it has received permission to test brain chips on humans – the FDA is silent
[ad_1]
Elon Musk’s brain chip company Neuralink said it has received approval from the US Food and Drug Administration (FDA) to conduct its first human clinical trials. “We are pleased to announce that we have received FDA approval to launch our first human clinical trial! This is the result of the incredible work of the Neuralink team in close collaboration with the FDA and is an important first step that will one day allow our technology to help many people,” the company wrote in Twitter. However, the American regulator FDA, which grants such permits, has not yet commented on the situation, Reuters reports. Read also: Elon Musk’s company is accused of excessive killing of animals when testing a brain chip Illustrative photo: Neuralink Since 2016, the billionaire’s implant company has been developing implantable chips to treat neurological diseases and other conditions by connecting the brain to a computer. Neuralink chips, in particular, are designed to help blind people regain vision, and people with paralyzed parts of the body to regain mobility. At least four times since 2019, Musk has predicted that Neuralink will begin human trials, but the FDA has rejected the application. The company has now said that the regulator has given the go-ahead for human clinical trials. At the same time, Neuralink says that they have started recruiting research participants. The FDA regulator itself has not yet confirmed the information about the granting of the corresponding permission. We will remind you that billionaire Elon Musk believes that a brain chip can cure depression, autism, obesity, schizophrenia and a number of other diseases. He also stated that he is so confident in the development that he is ready to use the chip in his own children. In early 2022, Elon Musk’s company Neuralink requested permission from the US regulator to test the chips on humans, but was denied due to safety concerns. The FDA was concerned about the chip’s lithium battery and the risk of tiny parts of the implant migrating to other areas of the brain. The regulator also doubted that the chip could be removed without damaging the brain tissue. Read also: Musk’s startup implanted a chip in a monkey’s brain that allows you to play video games with the power of thought
[ad_2]
Original Source Link
